Doxorubicin for treatment of canine lymphosarcoma after development of resistance to combination chemotherapy

J Am Vet Med Assoc. 1981 Nov 15;179(10):1011-2.
No abstract available

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Dog Diseases / drug therapy*
  • Dogs
  • Doxorubicin / therapeutic use*
  • Drug Resistance
  • Drug Therapy, Combination / veterinary
  • Female
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / veterinary*
  • Male

Substances

  • Antineoplastic Agents
  • Doxorubicin